Nature’s Sunshine Products, Inc. has announced the launch of an underwritten secondary public offering of up to 2,854,607 shares of its common stock, to be sold by Fosun Pharma USA, Inc.

Shares of Dyne Therapeutics declined after the company commenced an underwritten public offering and said it had secured up to $275 million of debt financing. The stock fell 9.8% to $8.59 on Monday.

The Secondary Offering was made only by means of a prospectus supplement and accompanying prospectus that forms a part of the registration statement, copies of which may be obtained, when ...

SINGAPORE, June 12, 2025--Karooooo Ltd. ("Karooooo") announced the pricing of an underwritten secondary public offering (the "Offering") of 1,500,000 ordinary shares held by Isaias (Zak) Jose ...

CHICAGO, June 11, 2025--Byline Bancorp, Inc. ("Byline" or the "Company") (NYSE: BY) announced today the pricing of the previously announced public offering (the "Secondary Offering") of a total of ...

Nature’s Sunshine Products, Inc. Announces Launch of Secondary Public Offering of Common Stock Provided by GlobeNewswire Jun 25, 2025, 1:01:00 PM ...

The market for new offerings has thawed recently, and everyday investors can participate in IPOs through several different ...

Centuri Holdings, Inc. (NYSE: CTRI) (“Centuri” or the “Company”) today announced the pricing of an underwritten secondary public offering of 9,750,000 shares ...

Shares of Torrid Holdings fell after the company disclosed plans for a secondary offering of its common stock and a $20 million buyback. The stock was down 25% to $3.80 in after-hours trading on ...